The DSRU has been conducting drug safety studies for over 30 years in both primary and secondary care. As leaders in risk management, we have developed methodologies for drug safety studies, notably SCEM (Specialist Cohort Event Monitoring) and MPEM (Modified Prescription-Event Monitoring).

In addition, we participate in publicly funded research and development projects initiated by the European Commission.

For further information about our work, both past and present, please browse through the links in the panel on the left.